Medical and assistive devices are becoming smarter, but many still lack the ability to generate consistent, high quality data about how they are used in real life. Linz based startup Sendance is working to close that gap. The company has secured new funding as part of its ongoing third investment round, strengthening its position as an enabling technology provider for data driven health and mobility products.
A new boost in the third investment round
Sendance raised the latest capital through a convertible loan provided by Garage Angels. Electron Capital Partners had already participated earlier during the seed phase. While the company did not disclose the size of the latest tranche, total funding raised to date now stands at €2.6 million. The capital will be used to further develop Sendance’s sensor and data platform and to expand adoption among medical device and wearable manufacturers.
Building the data layer for physical health products
Founded in 2021, Sendance focuses on sensor technology that allows physical devices to collect meaningful health and mobility data. Its core innovation is a patented flexible sensor grid that can be embedded into a wide range of products, including orthopaedic insoles, prosthetics, exoskeletons, and other assistive or wearable systems.
Unlike single purpose sensors, Sendance’s platform supports multiple measurement types in one system. Manufacturers can capture pressure, force, temperature, and motion data simultaneously, providing a richer and more complete view of how devices perform and how users interact with them.
From prototyping to real world deployment
Sendance positions its technology as an end to end solution across the entire product lifecycle. During early development, manufacturers can use the sensor grid to validate design decisions and optimise ergonomics. As products move into production, the same technology can be scaled and embedded into commercial devices.
Data collected from the sensors is transmitted to Sendance’s cloud platform, where it can be analysed in real time. This allows manufacturers, clinicians, and researchers to monitor performance, identify usage patterns, and make evidence based improvements. The approach reduces reliance on laboratory testing alone and brings real world insight directly into product development and clinical evaluation.
Supporting better mobility and health outcomes
The company’s technology is designed to support improved outcomes in mobility focused applications. For example, in orthopaedic insoles or prosthetics, pressure and motion data can help identify uneven load distribution or gait issues. In exoskeletons or rehabilitation devices, real time feedback can support safer use and more personalised therapy.
Sendance’s platform is already being used by customers internationally, and the first commercial products featuring “sendance inside” technology are now entering the market. This marks a transition from development stage partnerships to real world deployment.
Scaling adoption across digital health and wearables
According to the company, the new investment will accelerate platform development and help more manufacturers add data driven capabilities to traditionally mechanical products. As healthcare, sports, and assistive technology increasingly shift toward digital and outcome based models, Sendance aims to become a foundational technology provider for companies that want to combine physical devices and data intelligence.
By enabling manufacturers to collect reliable, continuous data directly from devices in daily use, Sendance is positioning itself at the intersection of hardware, software, and digital health. The company believes this approach can unlock new product categories and more personalised, measurable approaches to health and mobility in the years ahead.